Good MorningEquity markets held steady on Wednesday after signs of economic resilience were offset by signs of weakness. The good news included earnings reports from Target and TJX Companies, which were better than expected and included improved guidance. The bad news included a revision to labor data that wiped out gains made this year.
Minutes from the last FOMC meeting helped support the market on Wednesday. The minutes indicate a high likelihood for an interest rate cut next month and easing economic headwinds for business and consumers.” Featured: Elon’s big $266,000 per second purchase (Ad) 
|
Technology | |
As the quarter winds down, investors can look at 13-F filings to determine what the best minds on Wall Street are planning for the coming months. The Securities and Exchange Commission (SEC) requires these filings whenever an individual investor or fund holds a significant enough stake in any give... Read the Full Story |
|
From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
|
Retail/Wholesale | |
Target Corporation (NYSE: TGT) recently released its earnings report for the second quarter of 2024. The company’s latest report exceeded the expectations of its analyst community, prompting a surge in investor confidence and Target’s stock price. The company reported strong financia... Read the Full Story |
|
Auto/Tires/Trucks | |
The late July and early August sell-off may have spooked many investors, but it also opened up some very tempting entry opportunities. Already, we’re seeing market-wide recovery rallies reclaim much of the lost gains, but there’s still some edge to be had for investors with the right l... Read the Full Story |
|
From Our Partners | | Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. | | Watch the documentary briefing and find out which side you land on |
|
Retail/Wholesale | |
Stanley Druckenmiller, a renowned investor with a stellar track record, has made headlines with his family office, Duquesne, selling its position in NVIDIA (NASDAQ: NVDA) after accurately predicting the AI boom and NVDA's subsequent surge. Druckenmiller first invested in NVIDIA in the fourth quart... Read the Full Story |
|
Markets | |
Paying taxes in retirement can be a pain, and while there’s no way to avoid them entirely, you can use certain tax-advantaged accounts to lighten the blow. Individual Retirement Accounts (IRAs) and 401(k) accounts are two of the primary vehicles used for tax breaks on savings, but they come ... Read the Full Story |
|
From Our Partners | | Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now.
Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen.
Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch. | | Watch how to access the legal backdoor before it closes. |
|
Technology | |
Advanced Micro Devices (NASDAQ: AMD) recently made an important announcement in the firm's efforts to catch up with NVIDIA (NASDAQ:NVDA) in the data center market. The semiconductor company announced that it will acquire the firm ZT Systems in a nearly $5 billion transaction.
So how does this pur... Read the Full Story |
|
Technology | |
Lam Research (NASDAQ: LRCX) is a lesser-known company in the semiconductor industry compared to powerhouses like NVIDIA (NASDAQ: NVDA) and Taiwan Semiconductor (NYSE: TSM), but it is an important one.
Let’s examine the company’s annual report to better understand its operations and i... Read the Full Story |
|
Auto/Tires/Trucks | |
One way that companies increase shareholder value is through stock buybacks. This is a process in which a company reduces the number of outstanding shares available to investors and increases the company’s earnings per share. Investors will hear the term share repurchases used synonymously w... Read the Full Story |
|
Technology | |
After the brief sell-off in the S&P 500 sparked by the so-called “carry trade” between the U.S. dollar and the Japanese yen, most investors thought that the bullish wave taking over the technology sector was over and done with. As it turns out, these were – and are – so... Read the Full Story |
|
Business Services | |
Global payment technology company Visa (NYSE: V) stock is up 2.7% year-to-date (YTD), underperforming the 16.62% gain for the S&P 500 index. The Federal Reserve Bank of New York reported a $27 billion rise in credit card debt to a record $1.14 trillion. Credit bureau TransUnion reported the ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. | | View Today's Stock Pick |
|
